Literature DB >> 16364492

Cellular and virological mechanisms of HBV drug resistance.

Stephen Locarnini1, William S Mason.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16364492     DOI： 10.1016/j.jhep.2005.11.036

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  59 in total

1.  Current status of antiviral therapy for hepatitis B.

Authors:  Daryl T-Y Lau; Wissam Bleibel
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

Review 2.  Antiviral therapies: focus on hepatitis B reverse transcriptase.

Authors:  Eleftherios Michailidis; Karen A Kirby; Atsuko Hachiya; Wangdon Yoo; Sun Pyo Hong; Soo-Ok Kim; William R Folk; Stefan G Sarafianos
Journal:  Int J Biochem Cell Biol       Date:  2012-04-16       Impact factor: 5.085

3.  HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients.

Authors:  Timothy Na Archampong; Ceejay L Boyce; Margaret Lartey; Kwamena W Sagoe; Adjoa Obo-Akwa; Ernest Kenu; Jason T Blackard; Awewura Kwara
Journal:  Antivir Ther       Date:  2016-05-11

4.  Ultradeep pyrosequencing and molecular modeling identify key structural features of hepatitis B virus RNase H, a putative target for antiviral intervention.

Authors:  Juliette Hayer; Christophe Rodriguez; Georgios Germanidis; Gilbert Deléage; Fabien Zoulim; Jean-Michel Pawlotsky; Christophe Combet
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

Review 5.  Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma.

Authors:  Li-Ping Chen; Jun Zhao; Yan Du; Yi-Fang Han; Tong Su; Hong-Wei Zhang; Guang-Wen Cao
Journal:  World J Virol       Date:  2012-12-12

Review 6.  New therapeutic vaccination strategies for the treatment of chronic hepatitis B.

Authors:  Jia Liu; Anna Kosinska; Mengji Lu; Michael Roggendorf
Journal:  Virol Sin       Date:  2014-01-17       Impact factor: 4.327

7.  Resistant mutants induced by adefovir dipivoxil in hepatitis B virus isolates.

Authors:  Su-Wen Jiang; Li-Peng Yao; Ai-Rong Hu; Yao-Ren Hu; Shi-Xiang Chen; Tao Xiong; Guo-Sheng Gao; Xiao-Yue Liang; Shi-Xiong Ding; Peng-Jian Weng
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 8.  [Viral hepatitis B und C].

Authors:  Markus Reiser
Journal:  Med Klin (Munich)       Date:  2009-05-16

Review 9.  Current treatment indications and strategies in chronic hepatitis B virus infection.

Authors:  George V Papatheodoridis; Spilios Manolakopoulos; Athanasios J Archimandritis
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

10.  Hepatitis B viral surface mutations in patients with adefovir resistant chronic hepatitis B with A181T/V polymerase mutations.

Authors:  Jeong Han Kim; Young Kul Jung; Moon Kyung Joo; Ji Hoon Kim; Hyung Joon Yim; Jong-Jae Park; Jae Seon Kim; Young-Tae Bak; Jong Eun Yeon; Kwan Soo Byun
Journal:  J Korean Med Sci       Date:  2009-01-19       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.